Volume : 11, Issue : 06, June – 2024
Title:
NANOSPONGES: A NOVEL CLASS OF DRUG DELIVERY SYSTEM – REVIEW
Authors :
V.Saikishore, Shaik Alisha, M.Divya, G.Divya, P.Shruthi, P.Saikrishna
Abstract :
Due to the emergence of nanotechnology, the concept of targeted drug delivery has gained widespread acceptance. However, this method of delivering drugs requires the use of a special drug delivery system known as“Nanosponge”.Nanosponge is a promising drug delivery system that can provide a predictable and effective release of drugs as they can accomodate both hydrophilic and lipophilic drugs. Nanosponges are tiny sponges with a size of virus, that have a three-dimensional network and a nanometric cavity. They can be filled with various drugs.The particles can be fast absorbed by the body and can cirulate in the body until they reach the targeted site. They then release their drugs in a controlled and predictable fashion. Cyclodextrins and other suitable crosslinking agents (carbonyl or dicarboxylates) in an appropriate ratio are used for the preparation of nanosponges. Due to their high drug loading capacity, nanosponges are ideal for the delivery of drugs with low solubility. This technology can be utilized for the treatment of various diseases. Aside from vaccines and enzymes, nanosponges can also be used as carriers for various types of drugs.The present review explains the characteristic features (advantages and disadvantages), method of preparation, characterization and potent applications of nanosponges in the field of drug delivery.
Keywords: Targeted drug delivery systems, Nanosponges, Hydrophilic and Hydrophobic drugs, Cyclodextrins, Cross linking agents, Controlled release.
Cite This Article:
Please cite this article in press V.Saikishore et al, Nanosponges: A Novel Class Of Drug Delivery System – Review.,Indo Am. J. P. Sci, 2024; 11 (06).
Number of Downloads : 10
References:
1. Trotta F, Cavalli R, Tumiatti W, Zerbinati O, Rogero C, Vallero R. Ultrasound-assisted synthesis of Cyclodextrin-based nanosponges. EP 1 786 841 B1; 2007.
2. David F. Nanosponge drug delivery system more effective than direct injection. www.physorg.com 01.06.2010, accessed on 20.12.2011.
3. Trotta F, Tumiatti V, Cavalli R, Rogero C, Mognetti B, Berta G. Cyclodextrin-based nanosponges as a vehicle for Antitumoral drugs. WO 2009/003656 A1; 2009.
4. Liang L, De-Pei L, Chih-Chuan L. Optimizing the delivery systems of chimeric RNA. DNA oligonucleotides beyond general oligonucleotide transfer. Eur. J. Biochem. 2002; 269: 5753–5758.
5. Jenny A, Merima P, Alberto F, Francesco T. Role of β- cyclodextrin nanosponges in polypropylene photooxidation. Carbohydrate Polymers, 2011; 86: 127– 135.
6. Leslie Z. Benet., BCS and BDDCS. Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability. Department of biopharmaceutical sciences, University of California, San Francisco, USA, 2007.
7. Renuka S, Roderick BW, Kamla P. Evaluation of the kinetics and mechanism of drug release from Econazole Nitrate nanosponge loaded carbapol hydrogel. Ind J Parm Edu Res, 2011; 45(1): 25- 31.
8. Renuka S, Kamla P. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation Pharm Dev Technol. 2011; 16(4):367-376.
9. Torne SJ, Ansari KA, Vavia PR, Trotta F, Cavalli R. Enhanced oral Paclitaxel bioavailability after administration of Paclitaxel loaded nanosponges. Drug Delivery, 2010; 17(6):419–425.
10. Ansari KA, Torne SJ, Vavia PR, Trotta F, Cavalli R. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture. Curr Drug Deliv, 2011; 8(2):194- 202.
11. Sharma R, Pathak K. Nanosponges: Emerging drug delivery system. Pharma Stud; 2010. p. 33-5.
12. Indira B, Bolisetti SS. Nanosponges: a new era in drug delivery. J Pharm Res 2012; 5:5293-6.
13. Susmitha, Charanjit, V Manisha Reddy, Naveena, V Ram Mohan Gupta. Nanosponges–a concise review of emerging trends. Int J Pharm Res Biomed Anal 2014; 3:1-6.
14. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 2005;6: E329-57.
15. Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: a novel class of drug delivery system-review. J Pharm Pharm Sci 2012; 15:103-11.
16. Trotta F, Zanetti M, Cavalli R. Cyclodextrin-based nanosponges as drug carriers. Beilstein J Org Chem 2012; 8:2091–9.
17. Farooq SA, Saini V. Application of novel drug delivery system in the pharmacotherapy of hyperlipidemia. J Chem Pharm Sci 2013; 6:138-46.
18. Trotta F, Dianzani C, Caldera F, Mognetti B, Cavalli R. The application of nanosponges to cancer drug delivery. Expert Opinion Drug Delivery 2014; 11:931-41.
19. Gidwani B, Vyas A. A comprehensive review of cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. BioMed Res Int 2015; 15:1-15.
20. Vyas A, Saraf S, Saraf S. Cyclodextrin based novel drug delivery systems. J Inclusion Phenom Macrocyclic Chem 2008; 62:23-42.
21. Shankar S, Linda P, Loredana S, Francesco T, Pradeep V, Dino A, Michele T, Gianpaolo Z, Roberta C. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm, 2010; 74: 193-201.
22. Rosalba M, Roberta C, Roberto F, Chiara D, Piergiorgio P, Leigh E, Li S, Roberto P. Antitumor activity of nanosponge-encapsulated Camptotechin in human prostate tumors. Cancer Res,2011; 71:4431
23. Khalid AA, Pradeep RV, Francesco T, Roberta C. Cyclodextrin-based nanosponges for delivery of Resveratrol: In Vitro characterisation, stability, cytotoxicity and permeation Study AAPS PharmSciTech, 2011; 12(1): 279-286.
24. William K, Benjamin S, Eva H. Synthesis and Characterization of Nanosponges for Drug Delivery and Cancer Treatment. www.Vanderbilt.edu accessed on 20.12.2011.
25. Shankar S, Vavia PR, Francesco T, Satyen T. Formulation of Betacyclodextrin based nanosponges of Itraconazole. J Incl Phenom Macrocycl Chem, 2007; 57: 89–94.
26. Naga SJ, Nissankararao S, Bhimavarapu R, Sravanthi S, Vinusha K. Nanosponges: a versatile drug delivery system. Int J Pharm Life Sci 2013; 4:2920-5.
27. Güngör S, Erdal MS, Aksu B. New formulation strategies in topical antifungal therapy. J Cosmet Dermatol Sci Appl 2013; 3:56.
28. Trotta F. Cyclodextrin nanosponges and their applications. Cyclodextrins in pharmaceutics, cosmetics, and biomedicine. Current and Future Industrial Applications 2011. p. 323-42.
29. Kaur G, Aggarwal G, Harikumar SL. Nanosponge: New colloidal drug delivery system for topical delivery. Indo Global J Pharm Sci 2015; 5:53-7.
30. Renu Kadian. Nanoparticles: a promising drug delivery approach. Asian J Pharm Clin Res 2018; 11:30-5.
31. Munster, V. J.; Koopmans, M.; van Doremalen, N.; van Riel, D.; de Wit, E. A novel coronavirus emerging in china – key questions for impact assessment. N. Engl. J. Med. 2020, 382, 692−694.
32. Wu, D.; Wu, T. T.; Liu, Q.; Yang, Z. C. The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 2020, 94, 44−48.
33. Wang, Y.; Zhang, D.; Du, G.; Du, R.; Zhao, J.; Jin, Y.; Fu, S.; Gao, L.; Cheng, Z.; Lu, Q.; Hu, Y.; Luo, G.; Wang, K.; Lu, Y.; Li, H.; Wang, S.; Ruan, S.; Yang, C.; Mei, C.; Wang, Y.; Ding, D.; Wu, F.; Tang, X.; Ye, X.; Ye, Y.; Liu, B.; Yang, J.; Yin, W.; Wang, A.; Fan, G.; Zhou, F.; Liu, Z.; Gu, X.; Xu, J.; Shang, L.; Zhang, Y.; Cao, L.; Guo, T.; Wan, Y.; Qin, H.; Jiang, Y.; Jaki, T.; Hayden, F. G.; Horby, P. W.; Cao, B.; Wang, C. Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020, 395, 1569−1578.
34. Bekerman, E.; Einav, S. Combating emerging viral threats. Science 2015, 348, 282−283.
35. Catanzaro, M.; Fagiani, F.; Racchi, M.; Corsini, E.; Govoni, S.; Lanni, C. Immune response in COVID-19: Addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct. Target. Ther. 2020, 5, 84.